8-K: KindlyMD Secures $206M Bitcoin-Backed Loan, Eyes $250M Convertible Notes
Debt Financing and Strategic Partnership Announcement
KindlyMD's subsidiary, Naka SPV 2, LLC, secured a $206 million Bitcoin-backed interim loan from Antalpha Digital Pte. Ltd. and entered a non-binding agreement for a potential $250 million secured convertible note issuance.
Summary
- Naka SPV 2, LLC, a wholly owned subsidiary of Kindly MD, Inc., entered into a Master Loan Agreement with Antalpha Digital Pte. Ltd. on October 6, 2025.
- The Antalpha Loan provides an aggregate principal amount of 206,000,000 USDT, bearing interest at 7.0% per annum.
- The loan will be advanced in tranches over up to five days, with the first tranche up to 150,000,000 USDT.
- The Antalpha Loan matures 30 days after the initial tranche, with an option to extend for an additional 30 days.
- Obligations under the loan are secured solely by Bitcoin or other agreed digital assets.
- Proceeds from the Antalpha Loan are intended to satisfy existing obligations under a Master Loan Agreement with Two Prime Lending Limited, dated September 30, 2025, and cover associated costs.
- Kindly MD also announced a non-binding agreement with Antalpha for a potential issuance of up to $250,000,000 in 5-year secured convertible notes.
- The convertible notes are intended to provide long-term financing, expand Bitcoin holdings in the Nakamoto Bitcoin Treasury, and serve general corporate purposes.
- The partnership aims to develop innovative financing tools for the Bitcoin market and accelerate Bitcoin adoption among public companies.
Sentiment
Score: 8
Explanation: The filing indicates strong strategic alignment and progress in securing financing for KindlyMD's Bitcoin treasury strategy. The interim loan replaces existing debt, and the potential for a significant long-term convertible note facility from a 'Bitcoin-native' partner is a very positive signal for the company's future direction and growth in the digital asset space. While the convertible notes are non-binding, the intent and partnership are highly favorable.
Positives
- Secured a significant interim loan of 206,000,000 USDT to replace existing obligations, indicating continued access to financing.
- Established a strategic partnership with Antalpha, a recognized fintech leader in digital asset financing, aligning with KindlyMD's Bitcoin treasury strategy.
- Entered a non-binding agreement for a potential $250,000,000 secured convertible note facility, signaling a path to substantial long-term financing.
- The potential convertible notes are intended to expand Bitcoin holdings and provide financing with less dilution risk compared to standard convertible debt.
- The partnership is a step towards creating specialized financial solutions for Bitcoin treasury companies, potentially benefiting the broader Bitcoin ecosystem.
Negatives
- The interim Antalpha Loan has a short maturity of 30 days, with only a 30-day extension option, requiring frequent refinancing or a quick transition to long-term solutions.
- The potential $250,000,000 convertible note issuance is currently a non-binding agreement to indicative terms, subject to negotiation and definitive documentation, meaning it is not guaranteed.
- The 7.0% per annum interest rate on the interim loan, while potentially competitive for digital asset-backed loans, represents a cost of capital.
Risks
- Bitcoin market volatility can significantly impact the value of collateral and the company's treasury holdings.
- Cybersecurity and custody risks associated with managing digital assets.
- Potential changes in laws or accounting standards related to cryptocurrency could adversely affect operations and financial reporting.
- Regulatory developments affecting Bitcoin or other digital assets may impose new restrictions or costs.
- Changes in the company's capital structure and governance could have adverse effects on the market value of its securities.
- The ability to retain customers, hire key personnel, and maintain relationships with suppliers and customers is crucial for business continuity.
- Inability to reduce expenses or access future financing or liquidity could hinder growth and operations.
- Adverse impacts from geopolitical events, health crises, supply chain disruptions, or changes in consumer behavior.
- Hard Forks or Airdrops affecting Loaned Assets or Posted Collateral could lead to demands for return of assets or impact ownership of new tokens.
- Events of Default under the loan agreement, such as failure to repay, pay fees, or transfer collateral, could lead to acceleration of obligations and liquidation of collateral.
Future Outlook
KindlyMD expects this partnership to be the first step in a long series of initiatives to benefit its portfolio, shareholders, and the Bitcoin ecosystem. The company anticipates developing additional solutions with Nakamoto that serve treasury companies at scale and further accelerate Bitcoin's adoption by public companies. The potential $250 million convertible note facility is intended to provide long-term financing and expand Bitcoin holdings.
Management Comments
- David Bailey, Chairman and CEO of KindlyMD, stated: "This partnership represents the power of Bitcoin companies backing Bitcoin companies. It's meaningful to work with a longstanding, mission-aligned Bitcoin company to create financial solutions for Nakamoto and the wider industry. Together with Antalpha, we are not only addressing today's financing needs but also laying the foundation for future structures tailored to the unique requirements of Bitcoin treasury companies. This is the first step in what we expect will be a long series of initiatives to benefit our portfolio, our shareholders, and the Bitcoin ecosystem at large."
- Mr. Bailey also commented: "As a Bitcoin-native company and market leader with an unmatched reputation for exceptional client services, Antalpha is the ideal partner for creating competitive, long-term financing options that understand Bitcoin's intrinsic properties as a treasury reserve asset."
- Dr. Derar Islim, COO and CEO of Antalpha Americas & EMEA, noted: "Nakamoto's vision for the industry and its strategy to invest in a global network of Bitcoin companies is aligned with our view of the industry's future. Antalpha understands the unique requirements of Bitcoin treasury companies and the specialized financing and technology services they need. Together, we are building new structures that bridge the gap between traditional financing and the realities of the Bitcoin market, with this agreement representing only the first step. We expect to continue developing additional solutions with Nakamoto that serve treasury companies at scale and further accelerate Bitcoin's adoption by public companies."
Industry Context
This announcement highlights a growing trend of specialized financing solutions emerging within the digital asset industry, particularly for companies adopting Bitcoin as a treasury reserve asset. The partnership between KindlyMD (through Nakamoto Holdings) and Antalpha, a Bitcoin-native fintech company, signifies a move towards integrating traditional corporate finance with the unique characteristics of digital currencies. It reflects an industry effort to bridge the gap between conventional financial structures and the evolving needs of companies managing significant Bitcoin holdings, aiming to accelerate broader institutional adoption of Bitcoin.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to assess the Antalpha loan or potential convertible notes against global benchmarks. It emphasizes Antalpha's leadership in Bitcoin mining supply chain financial services and its expansion into serving Bitcoin treasury companies, but without direct comparative data.
Stakeholder Impact
- Shareholders: Potential for reduced dilution risk with convertible notes compared to standard equity raises, and alignment with the company's Bitcoin treasury strategy could enhance long-term value.
- Creditors: The Antalpha Loan replaces existing obligations, potentially restructuring debt and improving the company's financial flexibility.
- Customers: No direct impact mentioned, but improved financial stability could support continued healthcare service delivery.
- Employees: No direct impact mentioned.
Next Steps
- Antalpha Loan to be advanced in separate tranches over a period of up to five days.
- Negotiation and agreement of definitive documentation for the potential $250,000,000 secured convertible notes.
- Continued development of additional financial solutions with Antalpha for treasury companies.
- Expansion of Bitcoin holdings in the Nakamoto Bitcoin Treasury.
Key Dates
| Date | Description |
|---|---|
| 2025-09-15 | Date of Mr. Bailey's Shareholder Letter emphasizing alignment among shareholders and financial partners. |
| 2025-09-30 | Date of the Master Loan Agreement between Naka SPV 2, LLC and Two Prime Lending Limited, which the Antalpha Loan intends to satisfy. |
| 2025-10-06 | Date Naka SPV 2, LLC entered into the Master Loan Agreement with Antalpha Digital Pte. Ltd. |
| 2025-10-07 | Date Kindly MD issued a press release announcing the Antalpha Loan Agreement and the non-binding agreement for potential convertible notes. |
Recommendation
buyThe filing demonstrates a clear strategic direction and execution for KindlyMD as a Bitcoin treasury vehicle. Securing an interim loan to replace existing debt and, more importantly, establishing a non-binding agreement for a substantial $250 million long-term convertible note facility with a 'Bitcoin-native' partner like Antalpha, signals strong commitment and capability to expand Bitcoin holdings and fund general corporate purposes. This strategic alignment and access to specialized financing are crucial for a company focused on digital assets and are likely to be viewed very positively by investors who believe in the long-term value of Bitcoin and KindlyMD's strategy.
Keywords
Bitcoin treasury, Digital asset financing, Convertible notes, SEC filing, NAKA, Antalpha, KindlyMD, Nakamoto Holdings, Cryptocurrency loan, Corporate finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.